Prevention of Edema,Flight Microangiopathy and Venous Thrombosis in Long Flights with Elastic Stockings. A Randomized Trial

Abstract

The LONFLIT1/2 studies have established that in high-risk subjects after long (> 10 hours) flights the incidence of deep venous thrombosis (DVT) is between 4% and 6%. The LONFLIT4 study has been planned to evaluate the control of edema and DVT in low-medium-risk subjects. The aim of this study was to evaluate edema and its control with specific flight stockings, in long-haul flights. In the first part of the study 400 subjects at low-medium risk for DVT were contacted; 28 were excluded for several nonmedical problems; 372 were randomized into 2 groups to evaluate prophylaxis with stockings in 7-8-hour flights; the control group had no prophylaxis. Below-knee, Scholl, Flight Socks, producing 14-17 mm Hg of pressure at the ankle, were used in the treatment group. The occurrence of DVT was evaluated with high-resolution ultrasound scanning (femoral, popliteal, and tibial veins). Edema was assessed with a composite score based on parametric and nonparametric measurements. Part II: In this part of the study 285 subjects at low-medium risk for DVT were included and randomized into 2 groups to evaluate edema prophylaxis in 11-12-hour flights; the controls had no prophylaxis while the prevention group had below-knee, Scholl, Flight Socks (comparable to part I).

Results. Part I: DVT evaluation. Of the 184 included subjects in the stockings group and 188 in the control group, 358 (96.2%) completed the study. Dropouts were due to compliance or connection problems. Age/sex distributions were comparable in the groups. Stockings Group: of 179 subjects (mean age 49; SD 7; M:F = 101:78), none had DVT or superficial thromboses. Control Group: of 179 subjects (mean age 48.4; SD 7.3; M:F = 98:81), 4 (2.2%) had a DVT. There were also 2 superficial thromboses. In total, 3.35% (6) subjects had a thrombotic event. The difference (p < 0.002) is significant. Intention-to-treat analysis detects 15 failures in the control group (9 lost + 6 thromboses) out of 188 subjects (7.9%) versus 5 subjects (2.7%) in the stockings group (p < 0.05). All thrombotic events were observed in passengers sitting in nonaisle seats. The tolerability of the stockings was very good and there were no complaints or side effects. Thrombotic events were asymptomatic. No difference was observed in the distribution of events between men and women. The 3 women who had a thrombotic event were taking low-dose, oral contraceptives. Edema evaluation: The level of edema at inclusion was comparable in the 2 groups. After the flight there was a score of 6.7 (3.1) in controls; in the stockings group the score was 2.9 times lower (p < 0.05). The control of edema with stockings was clear considering both parametric (circumference, volume) and nonparametric (analogue scale lines) data. Part II: DVT evaluation. Of the 285 included subjects, 271 (95%) completed the study. Dropouts were due to low compliance or connection problems. Age/sex distributions were comparable in the groups. Stockings Group: of 142 subjects (mean age 48; SD 8; M:F = 89:53), none had DVT or superficial thromboses. Control Group: of 143 subjects (mean age 47; SD 8; M:F = 87:56), 3 had a popliteal DVT and 3 a superficial thrombosis. In total, 4.2% (6) subjects had a thrombotic event. The difference (p < 0.02) between groups is significant. Intention-to-treat analysis detects 14 failures in the control group (8 lost + 6 thromboses = 9.7%) versus 6 (all lost = 4.2% in the stockings group) (p < 0.05). Four of 6 events (3 DVT + 1 SVT) were observed in non-aisle seats. The tolerability of the stockings was very good. No difference was observed in the distribution of events between men and women. Edema evaluation: The level of edema at inclusion was comparable in the 2 groups. After the flight there was a score of 8.08 (2.9) in controls while in the stockings group the score was 2.56 (1.5) (p < 0.005). In conclusion. Scholl Flight Socks are very effective in controlling edema. Also this type of compression is effective in significantly reducing the incidence of DVT and thrombotic events in low-medium-risk subjects, in long-haul flights.

Conclusions: Considering these observations, Flight Socks are effective in controlling edema and in reducing the incidence of DVT in low-medium-risk subjects, in long-haul flights (7-11 hours).

Get full access to this article

View all access options for this article.

References

Geroulakos G. , Hossain J. , Tran T. : Economy-class syndrome presenting as phlegmasia caerulea dolens. Eur J Vasc Endovasc Surg 20:102-104, 2000.

Perry K. : Blood clot kills woman after flight. Guardian Oct 23, 2001.

Homans J. : Thrombosis of the deep leg veins due to prolonged sitting. N Engl J Med 250:148-149, 1954.

Symington IS , Stack Bhr : Pulmonary thromboembolism after travel. Br J Chest 17:138-140, 1977.

Simpson K. : Shelter deaths from pulmonary embolism. Lancet 11:744, 1940.

Ferrari E. , Chevallier T. , Chapelier A. , et al: Travel as a risk factor for venous thromboembolic disease: A case control study. Chest 115:440-444, 1999.

Kraaijenhagen R. , Haverkamp D. , Koopman Mmw , et al: Travel and risk of venous thrombosis . Lancet 356:1492-1493, 2000 .

Cruickshank JM , Gorlin R. , Jennett B. : Air travel and thrombotic episodes: The economy class syndrome. Lancet 2:497-498, 1988.

Sarvesvaran R. : Sudden natural deaths associated with commercial air travel. Med Sci Law 26:35-38, 1986.

10.

Landgraf H. , Vanselow B. , Schulte-Huerman D. , et al: Economy class syndrome: Rheology, fluid balance, and lower leg oedema during a simulated 12-hour long-distance flight. Aviat Space Envir Med 65:930-935, 1994.

11.

AMA Commission on Emergency Services : Medical aspects of transportation aboard commercial aircraft. JAMA 247:1007-1011, 1982.

12.

Gertler JP , Perry L. , L'Italien G. , et al: Ambient oxygen tension modulates endothelial fibrinolysis. J Vasc Surg 18:939-946, 1993.

13.

Bendz B. , Rostrup M. , Sevre K. , et al: Association between acute hypobaric hypoxia and activation of coagulation in human beings. Lancet 356:1657-1658, 2000.

14.

Belcaro G. , Geroulakos G. , Nicolaides AN , et al: Maladie veineuse thrombo-embolique apres vol aerien. Les etudes LONFLIT. Angeiologie 53:17-21, 2001.

15.

Belcaro G. : Venous thrombosis and air-travel: Prevention with aspirin or low-molecular-weight heparin. Circulation 104(suppl II):II-528, 2001.

16.

Belcaro G. , Geroulakos G. , Nicolaides AN , et al: Prevention of deep venous thrombosis on long-haul flights. J Am Coll Cardiol 39(suppl 5):212A, 2002 .

17.

Belcaro G. , Geroulakos G. , Nicolaides AN , et al: Venous thromboembolism from air travel. The Lonflit Study. Angiology 52:369-374, 2001.

18.

Cesarone MR , Belcaro G. , Nicolaides AN , et al: Venous thromboembolism from air travel: The Lonflit3 study. Prevention with aspiring vs low-molecular-weight heparin (LMWH) in high-risk subjects: A randomized trial. Angiology 53:1-6, 2002.

19.

Anonymous : Stockings, heparin found to eliminate "coach class" syndrome. American Heart Association Scientific Sessions Nov 14, 2001, p 8.

20.

Belcaro G. , Nicolaides AN , Veller M. : Venous Disorders: A Manual of Diagnosis and Treatment. Cambridge, UK: Saunders, 1996.

21.

Belcaro G. , Nicolaides AN : Noninvasive investigations in vascular disease. London : Imperial College Press, 2001.

22.

Thulesius O. : Chronic venous insufficiency and varicose veins. Physiopathological view points. Lakartidningen 80:1791-1801, 1983.

23.

Cesarone MR , Belcaro G. , Nicolaides AN , et al: The edema tester in the evaluation of swollen limbs in venous and lymphatic disease. Panmin Med 41:10-14, 1999.

24.

Belcaro G. , Bollinger A. , Hoffman U. , et al: Laser-Doppler. London: Med-Orion, 1995.

25.

Belcaro G. , Nicolaides AN , Stansby G. : The Venous Clinic. London: Imperial College Press, 1999.

26.

Belcaro G. , Nicolaides AN , Veller M. : Vascular Screening. Turin: Ed Minerva Medica, 1995.

27.

Calder S. : Exercise your constitutional rights in the air. The Independent , Jan 13, 2001.

28.

The fit flyer. High Life magazine. Dec 2000.

29.

Scurr JH , Machin SJ , Bayley S. , et al: Frequency and prevention of symptomless deep-vein thrombosis in long-haul flights: A randomised trial. Lancet 357: 1485-1489, 2001.

30.

James J. : Perils of passage. Time, 2001, pp 54-59.

31.

Eklof B. : Report from the WHO meeting in Geneva, March 2001 (unpublished, manuscript in preparation).

32.

Cesarone MR , Meli E. : Volare con Sicurezza. Jet-leg. II. problema dell'edema e della trombosi in voli di lunga durata. Turin : Ed Minerva Medica, 2001.

33.

Webster B. : Airlines tell passengers to stretch legs. Times Jan 12, 2001, p 1.

34.

Geroulakos G. : The risk of venous thromboembolism from air travel. The evidence is only circumstantial. Editorial. BMJ 322:188, 2001.

35.

Cesarone MR , Belcaro G. , Geroulakos G. , et al: Flight microangiopathy in medium-to-long distance flights: Prevention of edema and microcirculation alterations with HR (Paroven®,Venoruton®; (beta-hydroxyethyl)-rutosides: A prospective-randomised, controlled trial. J Cardiovasc Pharmacol Ther 7(suppl I):S17-20, 2002 .

36.

Nicolaides AN : Investigation of chronic venous insufficiency: A consensus statement. Circulation 102: 126-163, 2000.